ICD-10-CM Billable Code

F15.95

Other stimulant use, unspecified with stimulant-induced psychotic disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

Stimulants are a class of drugs that increase alertness, attention, and energy. They are often used medically for conditions like Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy but are also commonly misused recreationally. When stimulant use is excessive or prolonged, it can lead to serious mental health issues, including stimulant-induced psychotic disorder. This condition involves the development of psychotic symptoms, such as hallucinations or delusions, directly attributed to the effects of stimulant drugs. Understanding this disorder is vital for recognizing the risks associated with stimulant misuse and managing the associated health concerns.

Causes & Symptoms

Clinical Causes: Use of high doses of stimulant drugs such as cocaine, methamphetamine, or amphetamines Prolonged or repeated use of stimulant substances Rapid increase or escalation in dosage of stimulant drugs Pre-existing mental health conditions that may make individuals more susceptible Particular genetic or biological factors that influence drug metabolism and brain sensitivity

Key Symptoms: Hallucinations: seeing, hearing, or feeling things that are not present Delusions: fixed false beliefs despite evidence to the contrary Agitation or restlessness Paranoia or extreme suspicion Confusion or disorganized thinking Elevated mood or euphoria followed by irritability Rapid speech or racing thoughts Paranoia and aggressive behavior in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive assessment by a healthcare professional, including a detailed history of stimulant use and mental health evaluation. Clinicians look for recent stimulant use correlated with the onset of psychotic symptoms. Laboratory tests, such as urine or blood drug screens, can confirm recent stimulant intake. Mental health assessments also help differentiate stimulant-induced psychosis from other psychiatric conditions.

Treatment Protocols: Managing stimulant-induced psychotic disorder generally requires a multidisciplinary approach. Primary strategies include: - **Cessation of Stimulant Use:** Discontinuing stimulant drugs is crucial and often the first step. - **Supportive Care:** Monitoring symptoms and ensuring patient safety. - **Medications:** Antipsychotic drugs may be prescribed to manage psychotic symptoms temporarily. - **Psychological Support:** Counseling or therapy to address substance use behaviors and underlying mental health issues. - **Long-term Rehabilitation:** Addressing addiction through outpatient or inpatient programs to prevent relapse. Recovery from stimulant-induced psychosis often involves addressing both the mental health and substance use aspects, with ongoing support tailored to individual needs.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F15.95 a billable ICD-10 code?
Yes, F15.95 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F15.95?
Clinical documentation must specify the nature of Other stimulant use, unspecified with stimulant-induced psychotic disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference